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ABSTRACT 15 
Objective: Breast cancer (BC) is the most diagnosed cancer in women. Increasing survival rates 16 
shifts attention to preventive strategies. Obesity and intestinal microbiota (IM) composition may be 17 
associated with BC. Mediterranean Diet (MD) proved to be protective. The aim of this study was to 18 
assess the efficacy of probiotics in addition to MD versus diet alone in influencing gut microbiota 19 
and metabolic profile in overweight BC survivors. 20 
Methods: 34 BC survivor were randomized to MD for 4 months plus 1 sachet/day of probiotics 21 
(Bifidobacterium longum BB536, Lactobacillus rhamnosus HN001) for the first 2 months 22 
(intervention group, n=16) or MD alone for 4 months (control group, n=18). Anthropometric and 23 
nutritional assessments, adherence to MD, compliance to physical activity and metabolic 24 
parameters dosage were performed at baseline (T0), at 2 (T2) and at 4-months (T4). IM analysis 25 
was performed at T0 and T2. 26 
Results: After 2-months of probiotic administration the number of bacterial species (p=0.01) and 27 
the bacterial diversity assessed with the Chao1 index (p=0.004) significantly increased, no 28 
significant variations were detected after diet alone. The Bacteroidetes-/-Firmicutes ratio 29 
significantly decreased in the intervention group and increased in controls (p=0.004). Significant 30 
reductions of body weight, body mass index (BMI), fasting glucose and Homeostasis-Model 31 
Assessment Insulin-Resistance (HOMA-IR) were observed at T4 in both groups, in the intervention 32 
group also waist circumference (p=0.012), waist/hip ratio (p=0.045) and fasting insulin (p=0.017) 33 
significantly decreased. 34 
Conclusions: Probiotics in addition to MD positively influence the gut microbiota and improve 35 
metabolic and anthropometric parameters respect to MD alone. 36 
 37 
Keywords: gut microbiota, breast cancer, Mediterranean diet, probiotics 38 
 39 
 40 
ARTICLE 41 
Introduction 42 
Breast cancer (BC) is the most common cancer in women worldwide (1). Disparities in BC death 43 
rates are evident by state, socioeconomic status, and race/ethnicity, although overall survival rates 44 
have improved due to advancements in diagnosis and therapies (2). BC remains a major health 45 
problem, indeed research for primary and secondary prevention strategies represent a biomedical 46 
priority (3). Genetic, epigenetic and well-established determinants could explain a limited 47 
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number of BC cases. Bacterial communities within the host have been considered an additional 48 
environmental risk factor related to sporadic BC of unknown aetiology (4).  49 
Lifestyle could negatively impact on BC, especially alcohol consumption, fat excess, lack of 50 
physical exercise and poor diet (5,6). Overweight and obesity are associated with cancer advanced 51 
stage and grade at the diagnosis and resistance to local and systemic therapies (7–9). The largest 52 
collection of human-colonizing microorganisms is a complex cellular ecosystem localized at the 53 
distal gastrointestinal tract (colon), known as intestinal microbiota (IM) (10–12). The IM influences 54 
local and systemic physiological activities such as metabolic and immune functions, which become 55 
highly dysregulated during carcinogenesis (13). The composition of the gut microbiota modulates 56 
both inflammation and the genomic stability of host cells and thereby is involved in the initiation, 57 
progression and dissemination of cancer (14). BC is associated with oestrogen-dependent and 58 
oestrogen-independent functions of IM (15–21). 59 
Diet contents and quantity have a major role in shaping the gut microbiota composition and 60 
function (22). Obesity has been related to a distortion of the microbial homeostasis, with a reduced 61 
bacterial biodiversity and an altered expression of bacterial genes, especially those involved in 62 
energy extraction from food (23–25). A varied and balanced diet plays an essential role in 63 
maintaining the diversity and proper functioning of our gut microbiota. (26). The Mediterranean Diet 64 
(MD) is widely regarded as a healthy dietary pattern, due to the high intake of fiber and plant-65 
derived proteins, high levels of polyphenols and other antioxidants and healthy fatty acids (both 66 
monounsaturated and polyunsaturated) (27). 67 
Dietary supplementation with probiotics, such as bacterial strains exerting  beneficial effects on 68 
their host, regulates the gut microbiota structure and function through the interaction with the 69 
commensal bacteria and the expression of microbial enzymes (28). Lactobacilli and Bifidobacteria 70 
are the most used strains for safety and efficacy. Lactobacillus rhamnosus has been reported to 71 
improve insulin sensitivity and expression of genes related to glucose and lipid metabolism (29). 72 
Furthermore, the combination of the two probiotic strains Bifidobacterium longum and Lactobacillus 73 
rhamnosus has shown to be synergistic with positive endosymbiotic functional effects on the IM of 74 
the host (30). 75 
 The aim of this study was to assess the effect of a combination of two well-characterized 76 
probiotic strains (Bifidobacterium longum BB536, Lactobacillus rhamnosus HN001) in addition to 77 
MD on body weight, metabolic and inflammatory serum markers and gut microbiota composition 78 
compared to MD alone, in a cohort of overweight BC survivors. 79 
 80 
Materials and Methods 81 
Study design 82 
This is a randomized open-label pilot intervention trial. 83 
Recruitment of participants 84 
Participants were recruited from the Breast Unit - San Lazzaro Hospital of the "Città della Salute 85 
e della Scienza" of Turin, in the period from January 2017 to January 2018. 86 
Inclusion criteria were: female survivors to BC with BMI between 25.0 and 35.0 kg/m2, free 87 
from cancer disease.   88 
Exclusion criteria were: age over 70 years, any other chronic or acute diseases other than the 89 
previous BC, use of any supplement, use in the last 8 weeks of drugs for constipation, proton 90 
pump inhibitors, probiotics, antibiotics or any other drug potentially impacting on microbiota 91 
composition and metabolic parameters. 92 
 93 
Outcomes 94 
The primary outcome was the changes in the gut microbiota composition after 2 months of MD 95 
plus probiotics versus MD alone. 96 
Secondary outcomes were changes in body weight, body mass index (BMI), waist 97 
circumference and metabolic parameters after 4 months of intervention.  98 
 99 
Intervention 100 
Thirty-four female patients were randomized respectively to MD for 4 months plus 1 101 
sachet/day of probiotics for the first 2 months of the study (intervention group, n=16) or MD alone 102 
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for 4 months (control group, n=18). AlfaSigma S.p.a. (Bologna, Italy) provided the probiotic 103 
product, each sachet containing 4 × 109 colony-forming units (CFU) of B. longum BB536 and 109 04 
colony-forming units (CFU) of L. rhamnosus HN001). 105 
Data related to health status, use of drugs, supplements or probiotics, usual dietary habits and 106 
physical activity were collected from all subjects. 107 
All patients were evaluated at enrolment (T0), after 2 (T2) and 4 months (T4) from baseline. At 108 
each visit all subjects were assessed with: 109 
- nutritional assessment 110 
- the Italian Mediterranean Index (IMI) questionnaire 111 
- anthropometric measurements, such as height, weight, BMI, waist and hip circumference  112 
- metabolic parameters, such as blood count with leukocyte formula, fasting glucose, fasting 13 
insulin, glycated haemoglobin (HbA1c), aspartate amino transferase (AST), alanine amino 114 
transferase (ALT), γ-glutamyl transferase (GGT), C-reactive protein (CRP), 25OH-vitamin D, 115 
triglycerides, total and HDL cholesterol were obtained. LDL cholesterol was calculated with the 116 
Friedewald formula. 117 
At T0 and T2 faecal samples were collected to analyse the gut microbiota 118 
Nutritional assessment, anthropometric measurements and IMI questionnaire distribution were 119 
performed by a doctor with a trained dietitian. At the enrolment, after randomization, probiotics 120 
were provided to the intervention group. Patients took 1 sachet/day of probiotics 30 minutes 121 
before breakfast, for the first 2 months of the study. At T0, for each patient a personalized MD 22 
according to WCRF recommendations was elaborated (2) by a trained dietitian. Diet composition 123 
ranged from 1200 to 1500 kcal, with 15-18% proteins, 25-35% lipids and 45-55% carbohydrates. 124 
Each patient was encouraged to follow a diet rich in whole grains, fish, legumes, vegetables (at 125 
least 3 serving/day), fruits (2 serving/day), olive oil and seed oil, with a reduced intake of cheese, 126 
butter, meat, potatoes, and a very low content of sugars. 127 
Food and beverage consumption were assessed by a validated three-days food record (31,32). 128 
All participants were trained by a dietitian to record all food consumed.  129 
The compliance with the prescribed diet and physical activity and the adherence to the 130 
protocol was performed. A concordance to the prescribed diet ranging from 80 to 100% was 31 
arbitrarily defined as a good/very good, from to 50 to 80% as mild/moderate and below 50% as 132 
none compliance to diet. 133 
Physical activity was considered: none <1h/week, moderate 1-2h/week or intense >2h/week. 134 
The Italian Mediterranean Index (IMI) questionnaire is a food frequency questionnaire 135 
developed and validated by Agnoli et al. (33), to assess the adherence to a MD. The score is 136 
calculated from the qualitative and quantitative intake of 11 food items comprehending typical 137 
Mediterranean foods (pasta, typical Mediterranean vegetables, fruits, legumes, olive oil and fish) 138 
and non-typical Mediterranean foods (soft drinks, butter, red meat, and potatoes). If consumption of 139 
typical Mediterranean foods was in the 3rd tertile of the distribution (high intake), the person 40 
received 1 point; all other intakes received 0 points. If consumption of non-Mediterranean foods 141 
was in the 1st tertile of the distribution (low intake), the person received 1 point. Alcohol receives 1 142 
point for intake from 0.71 to 12 g/day; abstainers and persons who consume >12 g/day receive 0 143 
(33). Possible scores ranged from 0 to 11, we assumed a good adherence to MD with scores from 144 
6 to 11. 145 
Each visit was performed at the Department of Clinical Nutrition, San Giovanni Battista 146 
Hospital, of the “Città della Salute e della Scienza” of Turin. Blood samples were processed by the 147 
main hospital laboratory. Microbiological analysis of the faecal samples was performed at the 148 
Department of Agricultural, Forest and Food Sciences, University of Turin. 149 
 150 
Measurements 151 
Anthropometric parameters were measured by trained researchers. Body weight was measured 152 
to the nearest 0.1 kg, and height was measured to the nearest 0.1 cm with a stadiometer (Seca, 153 
Hamburg, Germany) and weight was measured with Tanita Segmental Body Composition 154 
Monitor 2012 (Tanita Corporation) with the participants wearing light clothes and no shoes. Waist 155 
circumference was measured at the navel level, without clothing by a plastic tape meter to the 156 
nearest 0.1 cm. Waist circumference was measured at the navel level, without clothing by a 157 
plastic tape meter to the nearest 0.1 cm. 158 
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Biochemical analysis 159 
Blood samples were collected after an overnight fast. All laboratory measurements were 60 
centralized. Serum glucose, AST, ALT, GGT, triglycerides and cholesterol (total and HDL-161 
cholesterol) and C-reactive protein (CRP) concentration were tested on COBAS 8000 Roche 162 
(Roche Diagnostics, Indianapolis). Total 25(OH)vitamin D was measured by Advia Centaur 163 
Siemens Healthcare Diagnostics analyser. Insulin was measured by Siemens Immulite analyzer. 164 
HbA1c was determined with Tosoff G8 analyzer. The HOMA-IR was calculated according to the 165 
published algorithm (34).  166 
 167 
Microbiological analysis 168 
DNA extraction 69 
Stool samples were self-collected at home by patients and transferred to sterile sampling 170 
containers. The samples were immediately refrigerated at 4 ° C and within the next 2 hours stored 171 
in a refrigerator at the temperature of -80 ° C. 172 
The total DNA was extracted directly from the faecal samples using the RNeasy Power 173 
Microbiome kit (Qiagen, Milan, Italy) following the manufacturer's instructions. One microlitre of 174 
RNase (Illumina Inc. San Diego, CA) was used for the digestion of RNA in DNA samples, with a 1 175 
hour incubation at 37°C. The DNA was quantified using the QUBIT dsDNA Assay kit (Life 176 
Technologies, Milan, Italy) and standardized at 5 ng/μL. 177 
 78 
Sequencing of the 16S rRNA gene target amplicon 179 
DNA extracted directly from the faecal samples was used to evaluate the microbiota by 180 
amplification of the V3-V4 region of the 16S rRNA gene using the primers and protocols described 181 
by Klindworth et al (35). PCR amplicons were purified with the Agencourt AMPure kit (Beckman 182 
Coulter, Milan, Italy) and the resulting products were tagged using the Nextera XT Index kit 183 
(Illumina Inc. San Diego, CA) according to the 16S metagenomic sequencing library preparation 184 
instructions. The paired-end sequencing reaction (2 X 250 bp) was performed using the Illumina 185 
MiSeq platform according to the manufacturer's instructions. 186 
 87 
Bioinformatic analysis of sequences 188 
The paired-end reads were assembled using the FLASH software (36) with the default 189 
parameters. The sequences were filtered by quality (Phred <Q20) using the QIIME 1.9.0 190 
software (37) and the sequences <250 bp were discarded via Prinseq (38). After chimeric filtering 191 
(39),  operational taxonomic units (OTUs) were clustered to 97% similarity through UCLUST (40) 192 
and the representative sequences of each cluster were mapped against the 16S rRNA database 193 
of Greengenes. 194 
 195 
Statistical analysis 96 
The α diversity of the intestinal microbiota was evaluated by the Chao1 index, which 197 
estimated the number of different taxa, and the Shannon diversity index, which evaluated the 198 
wealth and uniformity of the taxa calculated using the diversity of the vegan package (41) in R 199 
environment. The OTU table was used to build a principal component analysis (PCA) according 200 
to the sampling time using the made4 package of R. The ADONIS and ANOSIM tests were used 201 
to detect significant differences in the general microbial community using the Weighted UniFrac 202 
phylogenetic distance matrix and the OTU table. A principal component analysis (PCA) was 203 
carried out on the individual datasets (microbiota and anthropometric variable) and the results 204 
were then integrated using coinertia analysis (CIA), which allows the shared biological trends 205 
within two datasets. The statistical package DESeq2 was used to find significant differences in 206 
the abundance of microbial taxa. 207 
The comparison between groups was performed using the t-Student test or the U-Mann-208 
Whitney test in the case of non-normal distribution variables. The comparison within the same 209 
group was evaluated with the t test for paired data or the Wilcoxon matched pairs test in the case 210 
of not-normally distributed variables. A simple correlation analysis between anthropometric and 211 
laboratory variables and the individual OTUs (Spearman correlations) was performed. The 212 
significant associations were then further evaluated by multiple regression, after adjustment for 213 
age, BMI, and probiotic use. 214 
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Randomization 215 
A randomization list was drawn up by an operator who did not take part in the study. A number 216 
was assigned to each patient. The procedure was completely concealed to researchers.  17 
 218 
Blinding 219 
The study was not blinded. Indeed, the dieticians who evaluated the questionnaires and the 220 
laboratory personnel who analysed the blood and stool samples was blinded to the participants’ 221 
group assignment. 222 
 223 
Ethical aspects 224 
Each participant gave her written informed consent to participate to the study. The study 225 
protocol was approved by the Ethics Committee of the “Città della Salute e della Scienza” Hospital 26 
of Turin (approval date: March 30, 2017). 227 
 228 
Results 229 
Of the 34 participants, respectively 2 and 6 from the intervention group and the control group 230 
dropped out. The flow diagram of the trial is described in Figure 1. 231 
 232 
 233 
Figure 1. Flow diagram of the trial 234 
 35 
 236 
Anthropometric, metabolic and lifestyle characteristics 237 
Anthropometric, metabolic and lifestyle characteristics were not significantly different between 238 
the two groups at baseline (p>0.05).  239 
At the end of the study, we observed in the intervention group a significant reduction in body 240 
weight, BMI, waist circumference, waist/hip ratio, fasting glucose, insulin and HOMA-IR values 241 
(Table 1). The control group showed a significant reduction in body weight, BMI, fasting glucose 242 
and HOMA-IR levels and a significant increase in vitamin D (Table 1). Even if within-group (Table 243 
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1) and between-group (data not shown) differences were not significantly different, the CRP values 244 
tended to increase in the controls and to reduce in the intervention group. The delta values (final 245 
value minus baseline value of each variable) were not significantly different between-group, with 46 
the exception of ALT values (p=0.02) (data not shown).  247 
Participants from the intervention group showed a significant reduction in caloric intake and an 248 
increase of protein intakes (Table 1). All patients at T0 had a medium-low adherence to the MD, 249 
quantified by the Mediterranean Index. During the study, the adherence to the MD was stable in 250 
the intervention group but improved in the control group, though not significantly (Table 1). 251 
Similarly, the adherence to the recommended exercise improved in both groups, with a slightly 252 
higher, though not significantly different, increase in the controls (data not shown). 253 
 254 
Table 1. Comparisons of change from baseline for study endpoints in the two study arms. 255 
 Intervention group Control group 
Anthropometric and blood 
variables  
T0 T4 p T0 T4 p 
weight (kg) 81.5 ± 10.4 78.8 ± 9.9 0.001 75.5 ± 7.8 72.4 ± 7 0.015 
BMI (kg/m2) 31 ± 3.3 30.1 ± 3,2 0.003 30.1 ± 3.2 28.8 ± 2.5 0.013 
waist circumference (cm) 97 ± 10 94.4 ± 9.5 0.012 93.6 ± 10.9 90.4 ± 6.1 0.13 
hip circumference (cm) 109.7 ± 8.1 109.5 ± 7 0.87 108.7 ± 8.3 107 ± 6.8 0.16 
waist/hip ratio 0.88 ± 0.09 0.86 ± 0.07 0.045 0.86 ± 0.07 0.84 ± 0.04 0.39 
fasting glucose (mg/dL) 92.6 ± 10.5 86,7 ± 9,2 0.0025 92.5 ± 7.6 85.7 ± 11 0.017 
HbA1c (mmol/mol) 38.6 ± 3.3 38.3 ± 3.5 0.57 37.3 ± 4.3 37.2 ± 4.1 0.079 
insulin (µU/mL) 15.1 ± 8.1 12.6 ± 8.3 0.017 11.3 ± 4.6 9.4 ± 5.4 0.11 
HOMA-IR 
(mg/dL*µU/mL/405) 
3.5 ± 2.1 2.8 ± 2.1 0.004 2.6 ± 1.1 1.8 ± 1.2 0.024 
AST (UI/L) 20.4 ± 9.1 19.6 ± 4.3 0.65 18.1 ± 2.9 17.5 ± 2.7 0.21 
ALT (UI/L) 22.9 ± 14.4 21.4 ± 8.4 0.49 18.5 ± 5.1 14.6 ± 3.6 0.001 
GGT (UI/L) 23.7 ± 24.3 20.9 ± 17.2 0.67 21.4 ± 13.7 19 ± 11.9 0.16 
total cholesterol (mg/dL) 
206.6 ± 
34.4 
202.3 ± 34 0.67 202.1 ± 29.2 193.6 ± 21.7 0.50 
HDL-cholesterol (mg/dL) 57.9 ± 14.6 57.1 ± 13.9 0.76 55.7 ± 9.1 61.6 ± 14.5 0.15 
LDL - cholesterol (mg/dL) 
123.4 ± 
31.3 
120.5 ± 30.4 0.75 122.3 ± 24.1 115.7 ± 28.9 0.62 
triglycerides (mg/dL) 
126.5 ± 
63.4 
123.1 ± 67.5 0.69 104 ± 33.5 94.1 ± 33.1 0.20 
C-reactive protein (mg/L) 2.35 (1.30) 2.10 (2.70) 0.45 1.15 (1.95) 1.90 (2.40) 0.12 
25OH-vitamin D (ng/mL) 23.7±6.8 25.0±8.7 0.17 22.0±7.8 24.4±9.1 0.02 
Food intake             
Proteins (% kcal) 15.8 ± 2.9 18.7 ± 5.15 0.031 15.7 ± 3.5 16.9 ± 2.9 0.29 
Lipids (% kcal) 36.5 ± 5.2 38,5 ± 6.7 0.33 38.7 ± 6.4 36.1 ± 6.3 0.41 
Carbohydrates (% kcal) 46.5 ± 4.9 44.3 ± 11.0 0,47 42.2 ± 11.1 48 ± 7.3 0.24 
Energy (kcal/die) 
1431.4 ± 
441 
1102.5 ± 
208.1 
0.024 
1416.7 ± 
503.8 
1082.5 ± 
191.5 
0.058 
Mediterranean Index 6 ± 1.2 6 ± 1.1 0.85 5.7 ± 1.3 6.6 ± 0.9 0.075 
 256 
Body mass index (BMI); glycated hemoglobin (HbA1c), Homeostasis Model Assessment-Insulin Resistance 257 
(HOMA-IR); Alanine aminotranferase (ALT); aspartate aminotransferase (AST); γ-glutamil transferase (GGT). 258 
Mean ± SD (all such values); median (range) 259 
 260 
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Composition of intestinal microbiota at baseline (T0) and after 2-months of intervention (T2) 261 
A total of 1,944,328 (2 × 250 bp) were obtained after sequencing. After joining, a total of 262 
1,301,233reads passed the filters applied by QIIME, with a median value of 24720 (min 5092max 63 
49,644) reads/sample and a sequence length of 440bp. The rarefaction analysis and the estimated 264 
sample coverage indicated that there was a satisfactory coverage of all the samples (ESC median 265 
value of 96.48%). Moreover, the alpha-diversity showed that there were no differences, in terms of 266 
complexity (P > 0.05), between the dietary intervention (control vs. probiotic) at baseline as well as 267 
across time. Similarly, there was no significant separation by microbiota composition across time, 268 
dietary intervention or adherence to the Mediterranean diet (MD) of individuals in PCoA plots 269 
based on UniFrac distances (data not shown). However, by taking into the account microbiota 270 
composition and nutrients/metabolic variables we performed Coinertia analysis (CIA) (Figure 2) 271 
based on PCA of microbiota composition and nutrients/metabolic variables. The results showed a 72 
significant relationship between genus-level microbiota composition and probiotic intervention (RV 273 
coefficient=0.34; Monte Carlo p=0.001). 274 
The first component of the CIA (horizontal) accounted for 37.22% of the variance, and the 275 
second component (vertical) accounted for another 13.16%. Even if the CIA showed not clear 276 
separation of the datasets it is possible to observe a gradient of separation according to probiotic 277 
intervention (Figure 2). The statistical package DESeq2was used to find significant differences in 278 
microbial taxa abundance and the boxplot (Figure 3) showed statistically significant differences in 279 
several taxa (P <0.05) between T0 and T2. 280 
A significant increase both in number of bacterial species (p=0.01) and in bacterial diversity 281 
evaluated with the Chao1 index at T2 was observed in the treated subjects but not in controls 282 
(Table 2). 283 
At T0 in the intervention group lower levels of Clostridiales and higher levels of Escherichia 284 
were observed. At T2, in the probiotic treated group a significant increase of Eubacterium and L-285 
Ruminococcus (Ruminococcus assigned to the family Lachnospiraceae) and reduction in 286 
Bacteroides and Butirycicoccus were observed (Figure 3). 287 
The Bacteroidetes-/-Firmicutes ratio was similar in the two groups at T0, but it was significantly 288 
reduced in the probiotic treated subjects and increased in controls at T2, due to a reduction in 289 
Bacteroidetes and a simultaneous increase of Firmicutes after probiotic administration. 290 
 291 
 292 
 293 
Figure 2. Coinertia analysis combining PCA of microbiota, nutrient intakes and metabolic 294 
variables at T2. 295 
 296 
Subjects’ clustering and colouring were done according to the intervention (control =red; probiotic=blue). 297 
Arrow ends of the line indicate sample position in the microbiota dataset, while black dot end indicates 298 
sample position in the nutrient intakes and metabolic dataset. (PCA = Principal component analysis) 299 
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Table 2. Number of observed species and bacteria diversity indexes. 300 
  Intervention group Control group 
  T0 T2 p T0 T2 p 
Observed species 259.1 ± 50.4 296.4 ± 57.3 0.01 288.5 ± 44.2 288.6 ± 45.4 0.99 
Chao1 755.2 ± 171 903.1 ± 232.5 0.004 860.3 ± 193.3 792.8 ± 169.1 0.25 
Shannon 4.9 ± 0.5 5 ± 0.5 0.181 5.1 ± 0.4 5.3 ± 0.6 0.12 
 301 
 302 
Figure 3. Boxplots showing the relative abundance at genus or family level of the OTUs 303 
differentially abundant (P ≤ 0.05) in fecal samples between: control =red; probiotic=blue. 304 
 305 
Operational taxonomic units (OTU) 306 
 307 
Associations between microbiota, anthropometric, metabolic and lifestyle variables at T2. 308 
Several simple associations between microbiota and anthropometric, metabolic and lifestyle 309 
variables at T2 were detected (Figure 4). In summary, there were positive (direct) associations 310 
between: Akkermansia and lipid intake and HDL cholesterol levels; Barnesiellaceae and alcohol 311 
intake; Bifidobacterium and carbohydrate intake; Clostridiaceae and HDL levels; Clostridium, 312 
Bacteroides and Eggerthella and physical activity; Coriobacteriaceae and Mogibacteriaceae and 313 
protein intake; Dialister and HbA1c levels and Lachnospira and vitamin D. On the contrary, 314 
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negative (inverse) associations were found between: Roseburia and carbohydrate intake; 315 
Enterococcus and Lachnospira and CRP and ALT levels; Lachnospira and Clostridiales and total 316 
cholesterol levels; Clostridiales and LDL cholesterol; Dialister and physical activity; Bifidobacterium 317 
and blood sugar; Clostridiaceae and Mediterranean Index; Parabacteroides and HbA1c (Figure 4). 318 
In the multivariate model, after adjustment for age, BMI at T2 with probiotic use, a significant and 319 
inverse association between HbA1c values at T2 and Parabacteroides levels (Table 3) and 320 
between Roseburia and carbohydrate intake (Table 4), and a significant and direct association 321 
between Coriobacteriaceae and protein intake (Table 4) were detected. 322 
 323 
Figure 4. Simple associations between microbiota and anthropometric, metabolic and 324 
lifestyle variables at T2. 325 
 326 
Spearman’s rank correlation matrix of OTUs with > 0.2% abundance in at least 10 fecal samples, dietary 327 
information and blood variables. Strong correlations are indicated by large squares, whereas weak 328 
correlations are indicated by small squares. The colors of the scale bar denote the nature of the correlation, 329 
with 1 indicating a perfectly positive correlation (dark blue) and -1 indicating a perfectly negative correlation 330 
(dark red) between the two datasets. Only significant correlations (P <0.01) are shown. 331 
 332 
Table 3. Multivariate analysis of the associations between metabolic and inflammatory 333 
variables and bacteria at T2. 334 
 335 
Variables Bacteria beta SE p 
Fasting Glucose (mg(dL) Bifidobacterium -0.44 0.32 0.18 
HbA1c (mmol/mol) 
Dialister 0.11 1.64 0.94 
Parabacteroides -3.31 1.21 0.012 
ALT (UI/L) Enterococcus 1.27 2.50 0.62 
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Lachnospira -1.51 2.09 0.48 
Total Cholesterol (mg/dL) 
Clostridiales -16.8 9.00 0.08 
Lachnospira -7.54 6.99 0.29 
HDL-Cholesterol (mg/dL) 
Akkermansia 0.24 0.60 0.70 
Clostridiaceae 23.8 19.1 0.23 
LDL-Cholesterol (mg/dL) Clostridiales -13.8 8.51 0.12 
CRP (mg/L) 
Lachnospira -0.36 0.50 0.48 
Enterococcus -0.13 0.61 0.83 
Vitamin D (ng/mL) Lachnospira 2.46 1.88 0.20 
 336 
Multivariate regression, after adjustment for age, BMI at T2 and use of probiotics. 337 
Glycated hemoglobin (HbA1c); Alanine aminotranferase (ALT). 38 
SE= standard error 339 
 340 
Table 4. Multivariate analysis of the associations between food intakes, lifestyle and bacteria at 341 
T2. 342 
Variables Bacteria beta SE p 
Proteins (g/die) 
Coriobacteriaceae 0.070 0.029 0.024 
Mogibacteriaceae 0.007 0.008 0.40 
Lipids (g/die) Akkermansia 0.14 0.08 0.08 
Carbohydrates (g/die) 
Bifidobacterium 0.015 0.014 0.33 
Roseburia -0.05 0.02 0.04 
Alcohol intake Barnesiellaceae 3.15 1.82 0.10 
Mediterranean Index Clostridiaceae -0.18 0.36 0.63 
Physical Activity 
Bacteroides 0.29 0.69 0.67 
Clostridium -0.24 0.27 0.38 
Dialister 0.99 0.88 0.27 
Eggerthella -0.12 0.14 0.37 
Multivariate regression, after adjustment for age, BMI at T2 and use of probiotics. 343 
SE= standard error 344 
 345 
Discussion 346 
The ability of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 to colonize 347 
the intestinal environment and positively modulate the gut microbiota composition was previously 348 
reported in healthy subjects (42). BC survivors were assessed in our study and regression 349 
analyses have been adjusted for BMI, indeed data analysed separately in patients with overweight 350 
(n=12) and obesity (n=14) did not change significantly. In the intervention group a better glycidic 351 
homeostasis could be explained by an additional effect of probiotics, according to the literature 352 
(43–45). 353 
The close dietary follow-up and repeated nutritional counselling have probably led to a better 354 
compliance in dietary habits and food choices. Agrarian diet lead to an increase in Prevotella, while 355 
diets rich in proteins and fats to an increase in Bacteroides and Clostridiales (46–48). Here we 56 
observed a reduction in Bacteroides in probiotic treated subjects probably due to a reduction in 357 
protein and lipid intakes from T0 to T2. At T2 the Bacteroidetes/Firmicutes ratio decreased in the 358 
intervention group and increased significantly in controls, probably due to a progressive 359 
improvement in the adherence to the Mediterranean diet in the control group. 360 
L-Ruminococcus has been positively associated with omnivorous diets and particularly with animal 361 
based food (49). The decrease of L-Ruminococcus in controls could reflect a change in the dietary 362 
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habits on this group towards more vegetarian diets. Conversely, in the intervention group the 363 
increase of L-Ruminococcus could also be explained by probiotic administration (50).  364 
Even if within-group (Table 1) and between-group (data not shown) differences were not 365 
significantly different, the CRP values tended to increase in the controls and to reduce in the 366 
intervention group. We then observed in probiotic treated patient an increased in Butyricicoccus 367 
often associated with the low-fat diets (51), that could be beneficial because its ability of reducing 368 
the incidence and severity of inflammation or insulin sensitivity (52).  It should be pointed out that 369 
by the correlation analysis we observed an inverse relationship between Lachnospira and CRP 370 
value may have a protective role in inflammatory conditions (53). In addition, a positive association 371 
between these taxa with Vitamin D level was also observed. In a healthy gut microbial environment 372 
there is a link between microbes and vitamin D adsorption (54) and a positive effect of Lachnospira 373 
could be suggested. Obesity, diet and microbiota composition impact on Vitamin D blood levels, 374 
which is reduced in concomitant metabolic syndrome and gut dysbiosis related to a low-grade 375 
persistent inflammatory status (54–56). Interestingly Vitamin D increased significantly in the 376 
controls only, even if the between-group difference were not statistically different. This might be 377 
due a slight better compliance to physical activity and to MD with better food choice in the control 378 
group, although both assessed parameters did not reach statistically significance.  379 
Since patients increased the consumption of plant food stuff, an increase in dietary fiber intake 380 
could be related to the significative decrease of Eubacterium at T2 in both groups, as previously 381 
reported (57).   382 
The direct association between Coriobacteriaceae and protein intake could be explained by the 383 
substitution of animal with plant-derived proteins, mainly deriving from legumes, including soy. 384 
Coriobacteriaceae perform important intestinal functions such as the conversion of bile and steroid 385 
salts and the activation of food polyphenols (58,59). 386 
 387 
Limitations 388 
The small sample size and the limited follow-up represent both limitations of the present study, 389 
not allowing for a more detailed interpretation of the results. However, these are preliminary data of 390 
an explorative pilot trial in order to design a larger trial with a longer follow-up. Further limitations 391 
are the lack of gut microbiota analysis at T4 to assess later microbial shifts, as microbial 392 
communities are resilient and resistant to change (60), the lack of evaluation of psychological and 393 
cognitive aspects of participants, owing to the known interaction between those characteristics and 394 
the gut microbiota (61), and the lack of quality of life assessment, that could be modified by the 395 
microbiota modulation (62).  396 
 397 
 398 
Conclusions 399 
The present study contributes to interpreting the correlations between diet, lifestyle and gut 400 
microbiota in a selected group of breast cancer survivors. We found that the combination of 401 
probiotics Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001, administered daily 402 
for two months, positively influenced the microbiota composition. Importantly, a close follow up 403 
improved dietary habits, metabolic and anthropometric parameters; these findings were more 404 
evident in the group that took probiotics. Therefore, further studies are needed to demonstrate an 405 
effective correlation between the administration of probiotics, the lifestyle of the study subjects and 406 
the detectable changes of microbiota. 407 
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Appendix 431 
Table 5. Tertiles of intake of the Italian Mediterranean Index components (gr/day). 432 
 433 
Tertiles of intake of the Italian Mediterranean Index components (gr/day). 
Adapted from (33). 
ITEMS 1° TERZILE 2° TERZILE 3° TERZILE 
Pasta 0 – 37,9 38 – 71,8  71,9 – 431,5 
Olive oil 0 – 19,3 19,4 – 29,8 >29,9 
Mediterranean 
vegetables  
0 – 96,6 96,6 – 160  >160 
Fruits 0 – 249 249 – 391,8 >391,9 
Fish 0 – 20,1 20,2 – 38,5 >38,6 
Legumes 0 – 11,8 11,9 – 23,5 >23,5 
Red meat 0 – 69 69,1 – 111,9 112- 666,5 
Butter 0 – 0,2 0,3 – 1,3 1,4 – 101,1 
Potatoes 0 – 16,6 16,7 – 34,6 34,7 - 420,9  
Soft drinks 0 – 0,5 0,6 – 14,3 14,4 – 3000 
Alcohol    0 – 0,71 0,71 – 12,3 12,3 – 198,6 
 434 
 435 
IMI scores are calculated from qualitative and quantitative intake of 11 food items. 1 point is 436 
assigned for consumption of typical Mediterranean foods (pasta, typical Mediterranean vegetables, 437 
fruits, legumes, olive oil and fish) in the 3rd tertile and for non-Mediterranean foods (soft drinks, 438 
butter, red meat, and potatoes) in the 1st tertile of the distribution. Alcohol receives 1 point for 439 
intake from 0.71 to 12 g/day; abstainers and persons who consume >12 g/day receive 0. 440 
 441 
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 620 
HIGHLIGHTS
     
• Breast cancer (BC) is the most common cancer in women worldwide and style of 
life and diet could be impact with their appareance.
• Obesity and intestinal microbiota composition may be associated with breast cancer
and with a distortion of the microbial homeostasis, and reduced bacterial 
biodiversity.
• Overweight and obesity are associated with cancer advanced stage and grade at 
the diagnosis and resistance to local and systemic therapies.
• Dietary supplementation with probiotics, such as bacterial strains exerting.
 beneficial effects on their host, regulates the gut microbiota structure and function 
through the interaction with the commensal bacteria and the expression of microbial
enzymes.
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